| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5639 | Zinc69811181 | Novel ASCT2 inhibitor |
|
| DCC5640 | Zinpyr-1 | Cell-permeable fluorometric zinc sensor |
|
| DCC5641 | Zk187638 | Non-competitive AMPA receptor antagonist |
|
| DCC5642 | Zk230211 | Type III progesterone receptor antagonist with enhanced antiproliferative properties |
|
| DCC5643 | Zk-304709 | Novel oral multitarget tumour growth inhibitor |
|
| DCC5644 | Zk-806450 | Novel potent inhibitor of factor Xa (FXa) |
|
| DCC5645 | Zl006-05 | Novel dual mordulator of nNOS-PSD-95 interaction and GABA A receptor |
|
| DCC5646 | Zl0513 | Novel potent and selective BRD4 bromodomain 1 (BD1) inhibitor |
|
| DCC5647 | Zl0516 | Novel potent and selective BRD4 bromodomain 1 (BD1) inhibitor |
|
| DCC5648 | Zl3138 | Novel β-catenin/B-cell lymphoma 9 (BCL9) inhibitor, disrupting the β-catenin/BCL9 protein-protein interaction (PPI) with a Ki of 0.96 μM and without affecting the β-catenin/E-cadherin interaction in living cells, displaying good selectivity for β-catenin/ |
|
| DCC5649 | Zld10a | Novel potent and highly selective inhibitor of wild-type and mutant versions of EZH2 |
|
| DCC5650 | Zm-181037 | ATP-sensitive potassium channel-blocker; Eukalemic diuretic |
|
| DCC5651 | zm-189154 | Non-steroidal pure antioestrogen |
|
| DCC5652 | zm-230487 | 5-Lipoxygenase (5-LO) inhibitor |
|
| DCC5653 | Zm-244085 | K-Channel opener (PCO) activating predominantly KATP channels in vitro to relax bladder detrusors |
|
| DCC5654 | zm-253270 | Selective nonpeptide, NK-2 receptor (NK-2R) antagonist |
|
| DCC5655 | Zm-260384 | Potassium channel opener |
|
| DCC5656 | Zm39923 Hydrochloride | Potent, selective inhibitor of Janus tyrosine kinase 3 (JAK3) |
|
| DCC5657 | Zn-htsm | Novel antidiabetic agent for the treatment of type 2 diabetes mellitus (DM) |
|
| DCC5658 | Zofenoprilat | Inducer of functional angiogenesis through increased H 2 S availability |
|
| DCC5659 | Zolantidine Dimaleate | Potent, selective, and brain penetrating H2 receptor antagonist |
|
| DCC5660 | Zoledronate Disodium | Inhibitor of osteoclastogenesis and macrophage recruitment, decreasing bone turnover and stabilizing the bone matrix, exhibiting diverse anti-tumor effects in osteosarcoma |
|
| DCC5661 | Zolimidine | Gastroprotective agent for the treatment of peptic ulcer |
|
| DCC5662 | Zp1-12cl | Novel zinc sensor with a chloroalkane linker, reacting specifically with the engineered protein HaloTag, binding zinc ions with a threefold fluorescence enhancement |
|
| DCC5663 | Ztb23(r) | The first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor |
|
| DCC5664 | Ztz240 | Novel potentiator of KCNQ2 potassium channels |
|
| DCC5665 | Zu-4280011 | Novel COX-2 inhibitor |
|
| DCC5666 | Zuclopenthixol Dihydrochloride | Antagonist of D1 and D2 dopamine receptors. |
|
| DCC5667 | Z-wehd-fmk | Potent, cell-permeable and irreversible caspase-1/5 inhibitor |
|
| DCC5668 | Zwittermicin A | Natural antibiotic, having diverse biological activities including broad-spectrum antibiosis against Bacteria and lower Eukarya, plant disease suppression, and enhancement of the insecticidal activity of Bacillus thuringiensis toxin against lepidopteran l |
|
